Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Thumbnail

FDA clears 2D image-reconstruction product for 3D MRI

GE Healthcare may ship its deep learning-based image reconstruction software called AIR Recon DL with new 3D capabilities, the company announced Sept. 29.

Thumbnail

Transplanted lungs react to COVID in a distinctive way

Clinicians treating COVID-19 patients who have transplanted lungs and lower airway infection should order molecular testing in addition to, or regardless of, imaging findings.

Thumbnail

A new Alzheimer's drug therapy appears effective. What might this mean for the future of amyloid PET?

Previously, CMS determined that coverage for patients receiving treatment was dependent on their being enrolled in a CMS-approved clinical trial under coverage with evidence development (CED).

Thumbnail

Fetal MRI reveals how opioid use during pregnancy limits brain growth in utero

This study is one of the largest to date to assess brain growth in opioid-exposed fetuses in utero. 

CT imaging showing the congenital heart defect of left heart hypoplastic syndrome.

VIDEO: Congenital heart imaging with cardiac CT

As the population of patients with adult congenital heart disease grows, they are presenting to adult cardiology clinics and being imaged with CT. Many also do not have access or cannot be imaged by MRI, said Renee Bullock-Palmer, MD.

focused ultrasound Parkinson's

MRI-guided focused ultrasound an effective tool in the fight against Parkinson's disease

The results of a new trial offer “much needed progress” in the treatment of PD, experts involved in the study suggested. 

Thumbnail

22% of eligible young women have not undergone a mammogram yet

Also, up to 26% of eligible women have not had a formal conversation with their physician regarding their breast cancer risks, despite current guidelines that suggest these discussions start sooner rather than later.

Thumbnail

New amyloid buster significantly hinders Alzheimer’s advance

An experimental Alzheimer’s drug therapy has slowed cognitive and functional decline by 27% versus placebo in a double-blind, randomized study of 1,795 individuals with early signs and symptoms of the disease.